-
EP3057964
European procedure
Extract from the Register of European Patents
EP Citations: EP3057964
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2005007672
[A] (COLEY PHARM GMBH et al.) [A] 1-21 * claims 69-80 * | Type: | Non-patent literature | Publication information: | [A] COSTEDOAT-CHALUMEAU N ET AL: "Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?", JOINT BONE SPINE, ELSEVIER, PARIS, FR, vol. 77, no. 1, 1 January 2010 (2010-01-01), pages 4 - 5, XP026832816, ISSN: 1297-319X, [retrieved on 20100101] [A] 1-21 * the whole document * | Cited in | by applicant | Type: | Non-patent literature | Publication information: | KONO, H.; K.L. ROCK: "How dying cells alert the immune system to danger", NAT REV IMMUNOL, vol. 8, no. 4, 2008, pages 279 - 89 [A] 1-21 * the whole document * | Type: | Non-patent literature | Publication information: | KIROU, K.A. ET AL.: "Activation of the inter/eron-alpha at way identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease", ARTHRITIS RHEUM, vol. 52, no. 5, 2005, pages 1491 - 503 | Type: | Non-patent literature | Publication information: | MEANS, T.K. ET AL.: "Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9", J CLIN INVEST, vol. 115, no. 2, 2005, pages 407 - 17 | Type: | Non-patent literature | Publication information: | VOLLMER, J. ET AL.: "Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8", J EXP MED, vol. 202, no. 11, 2005, pages 1575 - 85 | Type: | Non-patent literature | Publication information: | SAVARESE, E. ET AL.: "Ul small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7", BLOOD, vol. 107, no. 8, 2006, pages 3229 - 34 | Type: | Non-patent literature | Publication information: | BANCHEREAU, J.; V. PASCUAL: "Type I interferon in systemic lupus erythematosus and other autoimmune diseases", IMMUNITY, vol. 25, no. 3, 2006, pages 383 - 92 | Type: | Non-patent literature | Publication information: | SHEN, N. ET AL.: "Sexspecific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus", PROC NATL ACAD SCI U S A, vol. 107, no. 36, 2010, pages 15838 - 43 | Type: | Non-patent literature | Publication information: | DENG, Y. ET AL.: "Micro NA-3 4 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus", PLOS GENETICS, 2013, pages E1003336 | Type: | Non-patent literature | Publication information: | GORDEN, K.B. ET AL.: "Synthetic TLR agonists reveal functional differences between human TLR7 and TLRB", J IMMUNOL, vol. 174, no. 3, 2005, pages 1259 - 68 | Type: | Non-patent literature | Publication information: | NICKERSON, K.M. ET AL.: "TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus", J IMMUNOL, vol. 184, no. 4, 2010, pages 1840 - 8 | Type: | Non-patent literature | Publication information: | FAIRHURST, A.M. ET AL.: "Yaa autoimmune phenotypes are conferred by overexpression of TLR7", EUR J IMMUNOL, vol. 38, no. 7, 2008, pages 1971 - 8 | Type: | Non-patent literature | Publication information: | DEANE, J.A. ET AL.: "Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation", IMMUNITY, vol. 27, no. 5, 2007, pages 801 - 10 | Type: | Non-patent literature | Publication information: | SAVARESE, E. ET AL.: "Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis", ARTHRITIS RHEUM, vol. 58, no. 4, 2008, pages 1107 - 15 | Type: | Non-patent literature | Publication information: | LAFYATIS, R.; M. YORK; A. MARSHAK-ROTHSTEIN: "Antimalarial agents: closing the gate on Toll-like receptors?", ARTHRITIS RHEUM, vol. 54, no. 10, 2006, pages 3068 - 70 | Type: | Non-patent literature | Publication information: | COSTEDOAT-CHALUMEAU, N. ET AL.: "Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus", ARTHRITIS RHEUM, vol. 54, no. 10, 2006, pages 3284 - 90 | Type: | Non-patent literature | Publication information: | CASANOVA, J.L.; L. ABEL; L. QUINTANA-MURCI: "Human TLRs and IL-lRs in Host Defense: Natural Insights fi om Evolutionary, Epidemiological, and Clinical Genetics", ANNU REV IMMUNOL, 2010 | Type: | Non-patent literature | Publication information: | "Remington: The Science and Practice of Pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS | Type: | Non-patent literature | Publication information: | "Encyclopedia of Pharmaceutical Technology", 1988, MARCEL DEK ER | Type: | Non-patent literature | Publication information: | FR6D6RIERIC DE MONTIGNY; GILLES ARGOUARCH; CLAUDE LAPINTE, SYNTHESIS, 2006, pages 293 | Type: | Non-patent literature | Publication information: | TSUZUKI, TETRAHEDRON ASYMMETRY, vol. 12, 2001, pages 29891 | Type: | Non-patent literature | Publication information: | HOLM, S.: "A simple sequentially rejective multiple test procedure", SCANDINAVIAN JOURNAL OF STATISTICS, vol. 6, no. 2, 1979, pages 65 - 70 |